Works matching IS 13479032 AND DT 2022 AND VI 113 AND IP 3
Results: 26
CXCR4 promotes the growth and metastasis of esophageal squamous cell carcinoma as a critical downstream mediator of HIF‐1α.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 926, doi. 10.1111/cas.15265
- By:
- Publication type:
- Article
Exosomes from M1‐polarized macrophages promote apoptosis in lung adenocarcinoma via the miR‐181a‐5p/ETS1/STK16 axis.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 986, doi. 10.1111/cas.15268
- By:
- Publication type:
- Article
Surgical volume threshold to improve 3‐year survival in designated cancer care hospitals in 2004‐2012 in Japan.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 1047, doi. 10.1111/cas.15264
- By:
- Publication type:
- Article
Utility of the Ba/F3 cell system for exploring on‐target mechanisms of resistance to targeted therapies for lung cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 815, doi. 10.1111/cas.15263
- By:
- Publication type:
- Article
Treatment patterns and survival in advanced unresectable esophageal squamous cell cancer: A population‐based study.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 1038, doi. 10.1111/cas.15262
- By:
- Publication type:
- Article
Complement C1q binding protein regulates T cells' mitochondrial fitness to affect their survival, proliferation, and anti–tumor immune function.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 875, doi. 10.1111/cas.15261
- By:
- Publication type:
- Article
Cancer immunotherapy using artificial adjuvant vector cells to deliver NY‐ESO‐1 antigen to dendritic cells in situ.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 864, doi. 10.1111/cas.15259
- By:
- Publication type:
- Article
ErbB4‐mediated regulation of vasculogenic mimicry capability in breast cancer cells.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 950, doi. 10.1111/cas.15258
- By:
- Publication type:
- Article
High prevalence of TERT aberrations in myxoid liposarcoma: TERT reactivation may play a crucial role in tumorigenesis.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 1078, doi. 10.1111/cas.15256
- By:
- Publication type:
- Article
Prognostic impact of circulating tumor cells detected with the microfluidic "universal CTC‐chip" for primary lung cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 1028, doi. 10.1111/cas.15255
- By:
- Publication type:
- Article
An aging‐related signature predicts favorable outcome and immunogenicity in lung adenocarcinoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 891, doi. 10.1111/cas.15254
- By:
- Publication type:
- Article
Identification of an IDO1‐based immune classifier for survival prediction of upper tract urothelial carcinoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 852, doi. 10.1111/cas.15253
- By:
- Publication type:
- Article
Development of an in vitro carcinogenesis model of human papillomavirus‐induced cervical adenocarcinoma.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 904, doi. 10.1111/cas.15246
- By:
- Publication type:
- Article
A modified MethyLight assay predicts the clinical outcomes of anti‐epidermal growth factor receptor treatment in metastatic colorectal cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 1057, doi. 10.1111/cas.15252
- By:
- Publication type:
- Article
Nanomedicine targets iron metabolism for cancer therapy.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 828, doi. 10.1111/cas.15250
- By:
- Publication type:
- Article
Next‐generation sequencing of endoscopically obtained tissues from patients with all stages of pancreatic cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 1069, doi. 10.1111/cas.15249
- By:
- Publication type:
- Article
Squalene synthase predicts poor prognosis in stage I‐III colon adenocarcinoma and synergizes squalene epoxidase to promote tumor progression.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 971, doi. 10.1111/cas.15248
- By:
- Publication type:
- Article
Enforced dual‐specificity tyrosine‐regulated kinase 2 expression by adenovirus‐mediated gene transfer inhibits tumor growth and metastasis of colorectal cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 960, doi. 10.1111/cas.15247
- By:
- Publication type:
- Article
Prognostic biomarker study in patients with clinical stage I esophageal squamous cell carcinoma: JCOG0502‐A1.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 1018, doi. 10.1111/cas.15251
- By:
- Publication type:
- Article
MEK inhibition suppresses metastatic progression of KRAS‐mutated gastric cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 916, doi. 10.1111/cas.15244
- By:
- Publication type:
- Article
NLRP4 negatively regulates type I interferon response and influences the outcome in anti‐programmed cell death protein (PD)‐1/PD‐ligand 1 therapy.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 838, doi. 10.1111/cas.15243
- By:
- Publication type:
- Article
PolyI:C attenuates transforming growth factor‐β signaling to induce cytostasis of surrounding cells by secreted factors in triple‐negative breast cancer.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 940, doi. 10.1111/cas.15241
- By:
- Publication type:
- Article
A phase 1 trial of xentuzumab, an IGF‐neutralizing antibody, in Japanese patients with advanced solid tumors.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 1010, doi. 10.1111/cas.15231
- By:
- Publication type:
- Article
Alpha‐actinin‐4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 1002, doi. 10.1111/cas.15228
- By:
- Publication type:
- Article
In this Issue.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 813, doi. 10.1111/cas.14948
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer Science, 2022, v. 113, n. 3, p. 809, doi. 10.1111/cas.14947
- Publication type:
- Article